Data from CIBMTR showing trends in HCT for primary MF between 2000 and 2014. (A) The number of transplants carried out in each year. (B) The percentage of transplants that used cord, bone marrow, or peripheral blood stem cells as the stem cell source. (C) The percentage of transplant recipients in different age groups (≤40 years, 41 to 60 years, and >60 years) and the percentage of transplants using a URD. The median age of MF HCT recipients for each time period is shown above each bar. (D) The percentage of transplants using RIC or FIC regimens. EMA, European Medicines Agency; FDA, Food and Drug Administration; FIC, full-intensity conditioning; RIC, reduced-intensity conditioning. Data used from CIBMTR with permission.